Advertisement
Screener

ATARA BIOTHERAPEUTICS, INC. (ATRA) Graph

2.8 / 5 stars · 68/120 Roast Me

ATRA Revenue Flow

ATRA Graph summary

Atara Biotherapeutics, Inc. (ATRA). Quarter ended 2024-09-30. Reported revenue sources, expenses and earnings; undisclosed amounts are not inferred.

How Atara Biotherapeutics, Inc. made money in the latest quarterLatest-quarter revenue sources flow through cost of revenue, gross profit, operating expenses, tax, and net income. $0.04B $-0.02B$0.04B$0.01B$0.00B$-0.02B$0.00B$-0.00B$-0.02B Revenue from contracts with customers, including assessed tax$0.04BDeclared revenue$0.04B Operating income$-0.02BResearch and development$0.04BGeneral and administrative$0.01BRestructuring charges$0.00BOther income, net$0.00BPre-tax income$-0.02BIncome tax$-0.00BNet income$-0.02B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Vaxart, Inc. (VXRT)United States$0.080B3.84
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Advertisement